Douglas Swirsky

Douglas Swirsky

Former Chief Financial OfficeratMaxcyte· In proxies 2023–2025

Pay in FY2025-27% from the year before · Maxcyte stock -62.7% the same year

Douglas Swirsky was paid $1.2M in FY2025 (Dec), down 27%. Maxcyte stock fell 62.7% that year.

Pay$100 in the stock at the end of FY22 → $28
Pay is from the Summary Compensation Table of each Maxcyte proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MaxcytePublic company · 3 yr
    • Former Chief Financial Officer2023 – Present · 3 yrStock in role -65%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?